IMMUNOGLOBULIN G, ANTI-(HUMAN INSULIN-LIKE GROWTH FACTOR I RECEPTOR) (HUMAN MONOCLONAL HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL LIGHT CHAIN, DIMER
Breast Tumors
QuantumLeap Healthcare Collaborativemonoclonal_antibodyPhase 2Active
CCC
50/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 35/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the Breast Tumors cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
L-Bupivacaine University Hospital, Antwerp | Phase 4 | BB |
ds-8201a UNICANCER | Phase 2 | BB |
Alisertib US Oncology Research | Phase 2 | B |
Pralatrexate Acrotech Biopharma Inc. | Phase 2 | B |
Ivonescimab Fudan University | Phase 2 | CCC |
Same molecule, other indications
IMMUNOGLOBULIN G, ANTI-(HUMAN INSULIN-LIKE GROWTH FACTOR I RECEPTOR) (HUMAN MONOCLONAL HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL LIGHT CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →